Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003143392 | SCV003828329 | uncertain significance | Insulin-dependent diabetes mellitus secretory diarrhea syndrome | 2021-07-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004246146 | SCV004872340 | uncertain significance | Inborn genetic diseases | 2024-01-02 | criteria provided, single submitter | clinical testing | The c.575C>T (p.P192L) alteration is located in exon 6 (coding exon 5) of the FOXP3 gene. This alteration results from a C to T substitution at nucleotide position 575, causing the proline (P) at amino acid position 192 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |